Good morning Luke, I'm happy to take onboard all opinions, condescending or otherwise. We are all as shareholder entitled to one. To clarify, I did not call it 'smokes and mirrors' (but I did appreciate the pun) - you read that in another post.
1. The timing of the MOU, and the stated relisting dates given by the BOD during those negotiations is what I am concerned about. "This goes to the heart of transparency, or lack thereof by this BOD. This also begs the question as to when the discussions with BioHealth and Medcan began and how many times we were given a relisting date during that process leading up to the MOU being agreed to."
2. I was not referring to the pending shareholder approval required, I was referring to shareholder approval that is currently in place from last year, which they now want to amend. The BOD are wanting to dismiss those votes now, and call another meeting prior to relisting. The end result could quite possibly be another 6 - 7 months of suspension, whereas they could relist and then call a meeting.
3. Shareholders have asked for clarification on the share allocation and / or refunds many, many times, and the date just gets put back. I for one don't want my hard earned potentially tied up not earning interest for me, or not put to work elsewhere for potentially 12 -14 months in total.
I have no beef with you or your opinions, we all have different perspectives and anticipations. Mine is to relist, then call a meeting and let the chips fall where they do. Those wanting out can take their funds, and those happy with the terms of the MOU / final agreement can vote on it. It comes down to transparency by the BOD, of which I personally feel is lacking.
Seems I may not have made myself clear enough in my post, but happy to take that one on the chin.
CGB Price at posting:
3.7¢ Sentiment: None Disclosure: Held
